V
Valérie Rolland-Neyret
Publications - 3
Citations - 23
Valérie Rolland-Neyret is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 19 citations.
Papers
More filters
Journal ArticleDOI
Ruxopeg, a Multi-Center Bayesian Phase 1/2 Adaptive Randomized Trial of the Combination of Ruxolitinib and Pegylated Interferon Alpha 2a in Patients with Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis
Jean-Jacques Kiladjian,Juliette Soret-Dulphy,Matthieu Resche-Rigon,Françoise Boyer-Perrard,Fiorenza Barraco,Valérie Rolland-Neyret,Claude Capron,Sylvie Chevret,Stéphane Giraudier,Bruno Cassinat +9 more
TL;DR: The RUXOPEG study was designed to assess the efficacy and safety of the combination of Rux + IFNa in MPN-associated myelofibrosis, and to identify the most efficacious dose combination that also satisfies safety requirements.
Journal ArticleDOI
Final Results of Ruxopeg, a Phase 1/2 Adaptive Randomized Trial of Ruxolitinib (Rux) and Pegylated Interferon Alpha (IFNa) 2a in Patients with Myelofibrosis (MF)
Jean-Jacques Kiladjian,Jean-Christophe Ianotto,Juliette Soret,Nabih Maslah,Cendrine Chaffaut,Françoise Boyer perrard,Fiorenza Barraco,Viviane Dubruille,Claude Capron,Amandine Tisserand,Valérie Rolland-Neyret,Zineb Ghrieb,Sylvie Chevret,Isabelle Plo,Marie-Hélène Schlageter,Véronique Meignin,Matthieu Resche-Rigon,Bruno Cassinat +17 more
TL;DR: The RUXOPEG study as discussed by the authors evaluated 9 possible combinations of doses of Rux, and IFNa (10, 15 and 20 mg BID, and 45, 90 and 135 mcg/week, respectively) and included 6 cohorts of 3 patients.
Journal ArticleDOI
Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim
Laurence Legros,Françoise Boyer perrard,Dana Ranta,Lydia Roy,Mario Ojeda-Uribe,Stéphane Giraudier,Nathalie Parquet,Jean-Christophe Ianotto,Mathieu Wemeau,Isabelle Plantier,Franck E. Nicolini,Eric Lippert,Pascale Cony-Makhoul,Fiorenza Barraco,Laure Stalnikiewicz,Frédéric Garban,Brigitte Dupriez,François Girodon,Anne Brignier,Yazid Arkam,Mathieu Meunier,Chloé James,Valérie Rolland-Neyret,Valérie Ugo,Pierre-Prosper Morel,Marie C. Béné,Jean-Jacques Kiladjian +26 more
TL;DR: In this paper , an observational COVIM study was conducted to assess the rate of severe COVID-19 infection in subgroups of French patients with MPN during the pandemic.